Literature DB >> 8455276

Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection.

W J Hopkins1, L J James, E Balish, D T Uehling.   

Abstract

Severe combined immunodeficient (SCID), T cell deficient, and immunocompetent mice were challenged intravesically with viable uropathogenic Escherichia coli. In comparison to immunocompetent controls, SCID mice had significantly greater numbers of viable E. coli in their bladders and kidneys 7 days after inoculation. Splenic anti-E. coli antibody-forming cells (AFC) were virtually absent in SCID mice at 7.0 days after infection. Adoptive transfer of spleen cells from E. coli-immunized immunocompetent mice to SCID mice enhanced their resistance to urinary tract infection (UTI), as evidenced by lower bacterial counts in bladder and kidneys following an induced infection. Congenitally T cell deficient nude mice and immunocompetent heterozygous controls had equivalent bladder and kidney infection levels at 2 and 7 days after UTI. Immunocompetency thus appears to play a significant role in resistance to E. coli UTI in this animal model. Since mice deficient only in T cells did not show increased UTI susceptibility, T cell-independent antibody responses may be an important immunologic defense mechanism.

Entities:  

Mesh:

Year:  1993        PMID: 8455276     DOI: 10.1016/s0022-5347(17)36260-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

Review 3.  Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.

Authors:  Valerie P O'Brien; Thomas J Hannan; Anthony J Schaeffer; Scott J Hultgren
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

4.  Bladder infection with uropathogenic Escherichia coli increases the excitability of afferent neurons.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Sheldon I Bastacky; Dennis R Clayton; Wily G Ruiz; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-15

Review 5.  Immunomodulation therapy offers new molecular strategies to treat UTI.

Authors:  Daniel Butler; Ines Ambite; Murphy Lam Yim Wan; Thi Hien Tran; Björn Wullt; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2022-06-22       Impact factor: 16.430

6.  Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.

Authors:  Erin C Hagan; Harry L T Mobley
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 7.  The innate immune response during urinary tract infection and pyelonephritis.

Authors:  John David Spencer; Andrew L Schwaderer; Brian Becknell; Joshua Watson; David S Hains
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

8.  Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection.

Authors:  W Hopkins; A Gendron-Fitzpatrick; D O McCarthy; J E Haine; D T Uehling
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 9.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 10.  Adhesive Pili in UTI Pathogenesis and Drug Development.

Authors:  Caitlin N Spaulding; Scott J Hultgren
Journal:  Pathogens       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.